Picture of SciBase Holding AB (publ) logo

SCIB SciBase Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: SciBase Says US Study Shows EIS And Nevisense Improves Clinicians' Diagnostic Accuracy

May 16 (Reuters) - SciBase Holding AB (publ)  SCIB.ST :
    * US STUDY SHOWS THAT EIS AND NEVISENSE SIGNIFICANTLY
IMPROVES
CLINICIANS' DIAGNOSTIC ACCURACY
    * NEW STUDY PUBLISHED IN US DEMONSTRATED THAT EIS AND
NEVISENSE
CAN SIGNIFICANTLY IMPROVE CLINICAL DECISIONS IN DERMATOLOGY
DAY-TO-DAY PRACTICE, ESPECIALLY FOR LESS EXPERIENCED CLINICIANS
    * CLINICIAN SENSITIVITY INCREASED FROM 66% TO 75% AND
SPECIFICITY
FROM 40% TO 70% WHICH IS A SIGNIFICANT IMPROVEMENT

Source text for Eikon:  ID:nWkr9FKf4y 
Further company coverage:  SCIB.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on SciBase Holding AB (publ)

See all news